Clinical Trials Logo

Sleep Apnea, Obstructive clinical trials

View clinical trials related to Sleep Apnea, Obstructive.

Filter by:

NCT ID: NCT04063436 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Start date: September 23, 2019
Phase: N/A
Study type: Interventional

This clinical trial is designed to evaluate the performance, comfort, and usability of a new nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in a home environment.

NCT ID: NCT04053153 Withdrawn - Sleep Apnea Clinical Trials

Effects of Upper Airway Muscle Training on Obstructive Sleep Apnea Severity

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of Asate Silent Sleep Training on obstructive sleep apnea (OSA) severity in patients with mild to moderate OSA. The Asate Silent Sleep Training is a muscle strengthening program that uses exercise equipment (a musical instrument that is based on the didgeridoo). The equipment is connected to an application, which provides instruction on how to perform the strengthening exercises, measures the sound produced by the musical instrument, which enables the app to provide feedback on whether the individual should blow less or more and also tracks adherence to the strengthening program.

NCT ID: NCT04021550 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Improving 24-hour Blood Pressure in Obstructive Sleep Apnea

Start date: May 2023
Phase: Early Phase 1
Study type: Interventional

This study examines the combined effects of an angiotensin receptor blocker (ARB), antioxidant supplementation, and continuous positive airway pressure (CPAP) therapy on the lowering of 24-hour blood pressure in persons with moderate to severe Obstructive Sleep Apnea (OSA). All participants will undergo CPAP therapy as prescribed by their doctor; however, half of the participants will receive the combined ARB and antioxidant treatment while the other half of the participants will receive a placebo.

NCT ID: NCT04013399 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Obstructive Sleep Apnea Treatment and Insulin Sensitivity in Pregnancy

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

This study will evaluate the effect of treatment of obstructive sleep apnea on insulin sensitivity in pregnant women. Women in their third trimester of pregnancy will be randomized to receive treatment or no treatment for one month.

NCT ID: NCT04011358 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study

SASOVR
Start date: September 2021
Phase: N/A
Study type: Interventional

This study purpose is to evaluate the association between Retinal Vein Occlusion and Obstructive Sleep Apnea.

NCT ID: NCT04009486 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Whole Body Vibration and the Brain in OSA

Start date: April 2020
Phase: N/A
Study type: Interventional

Participants will have an overnight polysomnography (recording apnea-hypopnea index), MRI (brain structure), and a sleep symptoms questionnaire for baseline data. Participants will then undergo 6 weeks of whole body vibration (using the whole body vibration device), 3 times a week for 30 minutes sessions. After 6 weeks, participants will have complete another polysomnography, MRI and sleep questionnaire.

NCT ID: NCT03875053 Withdrawn - Clinical trials for Locally Advanced Head and Neck Squamous Cell Carcinoma

Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer

Start date: July 25, 2023
Phase: N/A
Study type: Interventional

This trial studies information from a home sleep apnea machine to evaluate obstructive sleep apnea in patients with stage III-IV head and neck cancer. Sleep apnea (trouble breathing during sleep) can occur in head and neck cancer patients who have swelling in their neck. Wearing a sleep apnea machine overnight may help doctors evaluate obstructive sleep apnea in patients with head and neck cancer.

NCT ID: NCT03861468 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Medico-economics and QoL of Obese Patients Followed by Medical Analysis Laboratories (BIOSAOS )

BIOSAOS
Start date: September 14, 2019
Phase: N/A
Study type: Interventional

Obesity is a major risk factor for obstructive sleep apnea (OSA). However, OSA is still largely under diagnosed in patients with a high cardiovascular risk. In this population the STOP-BANG questionnaire facilitates OSA screening. Moreover, blood bicarbonate concentration is a simple tool to screen for chronic respiratory disease and if elevated, is a marker of cardiometabolic comorbidities in obese patients. A combination of blood bicarbonate concentration and STOP BANG score could provide a cost-effective method of screening for OSA in obese patients. Such screening could enable earlier management and might significantly reduce the costs of treatment and improve the quality of life of patients at 2 years.

NCT ID: NCT03743090 Withdrawn - Clinical trials for Coronary Artery Disease

Influence of Extracorporeal Circulation on the Development of OSA (Obstructive Sleep Apnea)

Start date: August 1, 2019
Phase:
Study type: Observational

- 1. Coronary artery bypass grafting (CABG) could be performed with or without extracorporeal circulation (ECC). - 2. OSA (Obstructive Sleep Apnea) could be influenced by in intravenous perfusion. - 3. ECC could influence the amount of intravenous perfusion administered to the patient. The aim of this study was to examine the influence of ECC on the development of OSA.

NCT ID: NCT03613558 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Dex as Analgesic Adjuvant in OSA Patients

Start date: July 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess whether intravenous peri-operative Dexmedetomidine reduces opioid requirements and or improves pain control after Uvulopalatopharyngoplasty (UPPP) in patients with obstructive sleep apnea (OSA).